March 19, 2020

COVID-19 | Guideline

COVID-19 Customer Guideline

3 Replies to “COVID-19 | Guideline”

Journal of Pharmacokinetics & Experimental Therapeutics is an open access journal that focuses on pharmacokinetic properties of drugs, including Absorption, Distribution, Metabolism and Excretion (ADME) while underlining the importance of experimental therapeutics in pharmacokinetic research. Journal of Pharmacokinetics & Experimental Therapeutics accepts manuscripts in clinical pharmacokinetics, population pharmacokinetics, antibody pharmacokinetics, pharmacokinetics review, vancomycin pharmacokinetics, tacrolimus pharmacokinetics, pharmacokinetic drugs, pharmacokinetics intravenous, pharmacokinetics oral, pharmacokinetics renal, pharmacokinetics human, pharmacokinetics rat, pharmacokinetics mice, pharmacokinetics for children, pharmacokinetics research to promote healthy life are welcome.
If your interested can submit your manuscript.
That manuscript should not published in any other journal pages.
You can submit your manuscript, to the below email id.
Email id:
Journal url:

We are professional API vendor with ten-year experience of export. We
are always happy to support customers and hope to help you on some
Following is our main items as your review:
Milbemycin oxime, Pimobendan, Selamectin, Spinosad, Trilostane, Tacrolimus
Cyclosporin, Daptomycin, Pneumocandin B0, Mupirocin, Teicoplanin,
Tobramycin, Vancomycin
Chlorambucil, Doxorubicin, Mitomycin C, Paclitaxel, Vinorelbine
Tartrate, Vinblastine Sulfate
Dexamethasone, Fluocinolone, Flumethasone, Hydrocortisone, Prednisolone
Dutasteride, Estradiol, Exemestane, Liothyronine, Levothyroxine
Glutathione, arbutin, Deoxyarbutin, Palmitoyl Tripeptide-1, Myristoyl
Tetrapeptide-12, Biotinoyl Tripeptide-1, GHK-Cu (Copper tripeptide-1)

Should you’d like to talk more, welcome to contact us at any time.
P.S. We are doing purchase for many customers around the world. For
any needs, please send me an email, let’s have further communication!

Best regards,
Emma Li
Sales Manager
TCS Group.
TEL: 86-512-85551896 | Email:
Skype: emmali87 | Whatsapp: 86-15051770250

Comments are closed.